VWA5B1
von Willebrand factor A domain-containing protein 5B1
Also known as: FLJ32784, VW5B1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TIE3
- Gene
- VWA5B1
- Ensembl
- ENSG00000158816
- Chromosome
- 1
- Canonical length
- 1220 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Mitochondria,Cytosol
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1220 residues, UniProt reviewed canonical sequence.
>Q5TIE3|VWA5B1
1 MPGLLNWITG AALPLTASDV TSCVSGYALG LTASLTYGNL EAQPFQGLFV YPLDECTTVI
61 GFEAVIADRV VTVQIKDKAK LESGHFDASH VRSPTVTGNI LQDGVSIAPH SCTPGKVTLD
121 EDLERILFVA NLGTIAPMEN VTIFISTSSE LPTLPSGAVR VLLPAVCAPT VPQFCTKSTG
181 TSNQQAQGKD RHCFGAWAPG SWNKLCLATL LNTEVSNPME YEFNFQLEIR GPCLLAGVES
241 PTHEIRADAA PSARSAKSII ITLANKHTFD RPVEILIHPS EPHMPHVLIE KGDMTLGEFD
301 QHLKGRTDFI KGMKKKSRAE RKTEIIRKRL HKDIPHHSVI MLNFCPDLQS VQPCLRKAHG
361 EFIFLIDRSS SMSGISMHRV KDAMLVALKS LMPACLFNII GFGSTFKSLF PSSQTYSEDS
421 LAMACDDIQR MKADMGGTNI LSPLKWVIRQ PVHRGHPRLL FVITDGAVNN TGKVLELVRN
481 HAFSTRCYSF GIGPNVCHRL VKGLASVSEG SAELLMEGER LQPKMVKSLK KAMAPVLSDV
541 TVEWIFPETT EVLVSPVSAS SLFPGERLVG YGIVCDASLH ISNPRSDKRR RYSMLHSQES
601 GSSVFYHSQD DGPGLEGGDC AKNSGAPFIL GQAKNARLAS GDSTTKHDLN LSQRRRAYST
661 NQITNHKPLP RATMASDPMP AAKRYPLRKA RLQDLTNQTS LDVQRWQIDL QPLLNSGQDL
721 NQGPKLRGPG ARRPSLLPQG CQPFLPWGQE TQAWSPVRER TSDSRSPGDL EPSHHPSAFE
781 TETSSDWDPP AESQERASPS RPATPAPVLG KALVKGLHDS QRLQWEVSFE LGTPGPERGG
841 AQDADLWSET FHHLAARAII RDFEQLAERE GEIEQGSNRR YQVSALHTSK ACNIISKYTA
901 FVPVDVSKSR YLPTVVEYPN SAALRMLGSR ALAQQWRGTS SGFGRPQTML GEDSAPGNGK
961 FQALNMEASP TALFSEARSP GREKHGASEG PQRSLATNTL SSMKASENLF GSWLNLNKSR
1021 LLTRAAKGFL SKPLIKAVES TSGNQSFDYI PLVSLQLASG AFLLNEAFCE ATHIPMEKLK
1081 WTSPFTCHRV SLTTRPSESK TPSPQLCTSS PPRHPSCDSF SLEPLAKGKL GLEPRAVVEH
1141 TGKLWATVVG LAWLEHSSAS YFTEWELVAA KANSWLEQQE VPEGRTQGTL KAAARQLFVL
1201 LRHWDENLEF NMLCYNPNYVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VWA5B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 13 nTPM
- pituitary gland: 11 nTPM
- kidney: 5 nTPM
- hypothalamus: 3.8 nTPM
- testis: 2.9 nTPM
- epididymis: 2.8 nTPM
Single-cell type
- somatotrophs: 295 nCPM
- epididymal clear cells: 282 nCPM
- choroid plexus epithelial cells: 263 nCPM
- ependymal cells: 223 nCPM
- renal collecting duct intercalated cells: 189 nCPM
- papillary tip epithelial cells: 64 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 47 nTPM
- midbrain: 16 nTPM
- pons: 13 nTPM
- medulla oblongata: 9.8 nTPM
- hypothalamus: 7.7 nTPM
- thalamus: 4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.97
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VWA5B1 as an antibody target. Whether an autoantibody or antibody against VWA5B1 could matter depends on whether native VWA5B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VWA5B1 is annotated as secreted, so native VWA5B1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label VWA5B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...